Immunocore Holdings (IMCR) P/E Ratio
P/E Ratio as of Jun 13, 2025: -79.02
Average-78.73
Median-80.43
Minimum-88.06
Maximum-69.20
-79.02
Past Month-12.81 (19.35%)
The P/E ratio for Immunocore Holdings (IMCR) is -79.02 as of Jun 13, 2025. This represents a increase of 118.77% compared to its 12-month average P/E ratio of -36.12. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Immunocore Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Immunocore Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Immunocore Holdings to industry peers.
Immunocore Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Immunocore Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Immunocore Holdings to industry peers.
Immunocore Holdings (IMCR) P/E Ratio Insights
See Immunocore Holdings’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Immunocore Holdings (IMCR)
Order type
Buy in
Order amount
Est. shares
0 shares
Immunocore Holdings (IMCR) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $38.65 | -88.06 |
| May 1, 2025 | $30.15 | -29.40 |
| Apr 1, 2025 | $28.63 | -27.92 |
| Mar 3, 2025 | $28.88 | -28.16 |
| Feb 3, 2025 | $31.17 | -32.58 |
| Jan 2, 2025 | $29.82 | -31.17 |
Immunocore Holdings (IMCR) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -79.02 | +156.31% |
| 2024 | -30.83 | +28.57% |
| 2023 | -23.98 | +19.72% |
| 2022 | -20.03 | +150.06% |
| 2021 | -8.01 | — |
FAQs About Immunocore Holdings (IMCR) P/E ratio
The latest P/E ratio of Immunocore Holdings (IMCR) is -79.02, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Immunocore Holdings’s last 12-month average P/E ratio is -36.12, compared to its current P/E ratio of -79.02. This reflects a increase of 118.77%.
Immunocore Holdings’s current P/E ratio of -79.02 is higher than its last 12-month average P/E of -36.12. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Immunocore Holdings’s average P/E ratio over the last 3 years is -30.41. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Immunocore Holdings’s average P/E ratio over the last 5 years is -19.12. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.